Sphere Medical Holding plc Sphere Medical Expands Sales into Belgium (3614I)
August 30 2016 - 2:01AM
UK Regulatory
TIDMSPHR
RNS Number : 3614I
Sphere Medical Holding plc
30 August 2016
30 August 2016
Sphere Medical Holding plc
("Sphere Medical" or the "Company")
Sphere Medical Expands Sales into Belgium
Sphere Medical Holding plc (AIM: SPHR.L), a leading provider of
innovative monitoring and diagnostic devices for the critical care
setting, announces the first sale of its Proxima system in Belgium
with an initial order to the Universitair Ziekenhuis Brussel, a 700
bed teaching hospital conducting scientific research, which has
evaluated the Proxima system during the past year.
After the UK and Germany, Belgium is the third country in which
Sphere Medical has sold Proxima devices through its direct sales
force.
Dr Wolfgang Rencken, Chief Executive Officer of Sphere Medical,
said: "Proxima is an innovative product which offers better patient
management during a patient's critical period, and faster and more
frequent production of blood gas, electrolyte and metabolite
results. We are pleased to bring Proxima to patients around Europe
and report sales in three countries now. As we look ahead to the
launch of Proxima 4, the opportunity to increase potential coverage
from around 10% of critical care patients to 40-50% gives us
optimism for the future."
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014.
- Ends -
For further information, please contact:
Sphere Medical Holding Tel: +44 (0)1223 875
plc 222
Dr Wolfgang Rencken, Chief
Executive Officer
Richard Wright, Chief
Financial Officer
Panmure Gordon Tel: +44 (0) 20 7886
2500
Freddy Crossley (Corporate
Finance)
Duncan Monteith (Corporate
Finance)
Tom Salvesen (Corporate
Broking)
Consilium Strategic Tel: +44 (0) 20 3709
Communications 5700
Mary-Jane Elliott spheremedical@consilium-comms.com
Chris Gardner
Ivar Milligan
Hendrik Thys
Notes for Editors
About Sphere Medical (AIM: SPHR.L)
Sphere Medical is an innovative point-of-care medical device
company. Its Proxima platform measures blood gases, electrolytes
and metabolites at the patient's bedside and aims to improve
patient care and reduce health system costs. The device is
currently sold directly to the critical care market via Sphere
Medical's sales force in the UK, Germany, The Netherlands and
Belgium. For further information, please visit
www.spheremedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPLMBTMBATTIF
(END) Dow Jones Newswires
August 30, 2016 02:01 ET (06:01 GMT)
Sphere Medical (LSE:SPHR)
Historical Stock Chart
From Apr 2024 to May 2024
Sphere Medical (LSE:SPHR)
Historical Stock Chart
From May 2023 to May 2024